PTGER4 and cervical carcinoma: There are currently several clinical trials (NCT03658772, NCT03152370, NCT04344795, NCT04432857) investigating EP4 inhibitors for the treatment of colorectal cancer and other solid tumors, including endometrial and cervical cancers.